Ensemble Group Holdings combines pioneering expertise in radiogenomics, medical AI, and drug discovery to help biotech and pharmaceutical companies de-risk drug development through AI and deep science. Includes independent research on drug mechanisms, resistance prediction, and biotech investment implications via Ensemble Research.